Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMajedie Inv. Regulatory News (MAJE)

Share Price Information for Majedie Inv. (MAJE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 245.00
Bid: 242.00
Ask: 248.00
Change: 0.00 (0.00%)
Spread: 6.00 (2.479%)
Open: 245.00
High: 0.00
Low: 0.00
Prev. Close: 245.00
MAJE Live PriceLast checked at -
Majedie is an Investment Trust

To maximise total shareholder return whilst increasing dividends by more than the rate of inflation over the long-term by investing in securities of publicly quoted companies worldwide, though it may invest in unquoted securities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

12 Mar 2024 10:08

RNS Number : 5234G
Majedie Investments PLC
12 March 2024
 

To: RNS

From: Majedie Investments PLC

LEI: 2138007QEY9DYONC2723

Date: 12 March 2024

 

 

Majedie Investments PLC (the "Company")

 

Appointment of new Director

 

The Board is pleased to announce the appointment of Heinrich Merz as non-executive Director of the Company with effect from 11 March 2024.

 

Heinrich is a Managing Director of Oxford University Endowment Management ("OUem") and is responsible for sourcing, diligence and evaluation of investments across all asset classes. Heinrich joined OUem in 2023 from Pictet Alternative Advisors, where he had been Head of Hedge Funds since 2017 and a member of the Pictet investment committee. He has previously held positions as CIO at Amundi Alternative Investments, overseeing alternative assets for institutional clients, and Deputy CIO at Permal Group. He began his career in alternative investments at Concordia Advisors, a multi-strategy hedge fund. Heinrich holds a master's degree from both Oxford and Columbia University, and is a Chartered Financial Analyst (CFA). He speaks English, German, French and Spanish.

 

There are no other details or disclosures required under LR 9.6.13R of the Financial Conduct Authority Listing Rules.

 

Christopher Getley, Chairman, commented "The Board is delighted that Heinrich has agreed to join Majedie as his investment experience and skills are entirely relevant to the liquid endowment strategy. We are confident that Heinrich's appointment will complement the Board's deliberations in enabling the achievement of its stated intention to grow the Company."

 

 

All enquiries:

Juniper Partners Limited (Company Secretary)Tel: 0131 378 0500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFIIVDIFLIS
Date   Source Headline
2nd Aug 20237:00 amRNSDividend Declaration
1st Aug 20234:12 pmRNSTotal Voting Rights
28th Jul 202311:52 amRNSDirector/PDMR Shareholding
25th Jul 202312:30 pmRNSNet Asset Value(s)
25th Jul 202312:29 pmRNSNet Asset Value(s)
10th Jul 20236:14 pmRNSNet Asset Value(s)
3rd Jul 202311:30 amRNSTotal Voting Rights
26th Jun 20236:13 pmRNSNet Asset Value(s)
26th Jun 20236:12 pmRNSNet Asset Value(s)
15th Jun 20235:53 pmRNSBlock listing Interim Review
12th Jun 20231:08 pmRNSNet Asset Value(s)
1st Jun 202312:30 pmRNSTotal Voting Rights
26th May 20237:00 amRNSHalf-year Report
25th May 20234:45 pmRNSNet Asset Value(s)
25th May 20234:43 pmRNSNet Asset Value(s)
10th May 20235:57 pmRNSNet Asset Value(s)
5th May 20237:00 amRNSDividend Declaration
2nd May 20235:04 pmRNSTotal Voting Rights
27th Apr 20235:58 pmRNSNet Asset Value(s)
27th Apr 20235:56 pmRNSNet Asset Value(s)
11th Apr 20239:33 amRNSNet Asset Value(s)
3rd Apr 20234:17 pmRNSTotal Voting Rights
30th Mar 20237:00 amRNSKepler Trust Intelligence: New Research
27th Mar 20235:32 pmRNSNet Asset Value(s)
27th Mar 20235:29 pmRNSNet Asset Value(s)
13th Mar 20233:39 pmRNSNet Asset Value(s)
1st Mar 20232:50 pmRNSRevised Timetable for Publication of the NAV
1st Mar 20232:39 pmRNSNet Asset Value(s)
1st Mar 20232:01 pmRNSTotal Voting Rights
28th Feb 20231:12 pmRNSNet Asset Value(s)
27th Feb 202312:48 pmRNSNet Asset Value(s)
24th Feb 202311:16 amRNSNet Asset Value(s)
23rd Feb 20233:30 pmRNSNet Asset Value(s)
22nd Feb 202312:24 pmRNSNet Asset Value(s)
21st Feb 202312:30 pmRNSNet Asset Value(s)
20th Feb 20233:51 pmRNSNet Asset Value(s)
17th Feb 20233:27 pmRNSNet Asset Value(s)
16th Feb 202312:50 pmRNSNet Asset Value(s)
15th Feb 202312:41 pmRNSNet Asset Value(s)
14th Feb 20232:32 pmRNSNet Asset Value(s)
13th Feb 20231:26 pmRNSNet Asset Value(s)
10th Feb 20232:15 pmRNSNet Asset Value(s)
9th Feb 20232:17 pmRNSNet Asset Value(s)
8th Feb 202312:47 pmRNSNet Asset Value(s)
7th Feb 20232:57 pmRNSNet Asset Value(s)
6th Feb 202312:48 pmRNSNet Asset Value(s)
3rd Feb 20231:44 pmRNSNet Asset Value(s)
2nd Feb 202312:06 pmRNSNet Asset Value(s)
1st Feb 20234:25 pmRNSTotal Voting Rights
1st Feb 20233:51 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.